AMANDA SMAY: Open Payments
NPI 1467102541 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 23 payments from 12 companies in 2025. Trend: 2023 $507 · 2024 $209 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 5 | $152 |
| Galderma Laboratories, L.P. | 4 | $86 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Amgen Inc. | 3 | $58 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| PFIZER INC. | 1 | $20 |
| Almirall LLC | 1 | $19 |
| GENZYME CORPORATION | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
Products named: SOFDRA, NEMLUVIO, COSENTYX, OTEZLA, DUPIXENT, ACTHAR, CIBINQO, Seysara.
Industry payments across FL — which companies pay providers there.
